Trial intelligence / Profile preview

Nicorandil for Cardiac Sympathetic Nerve Activity in STEMI

NCT04826497Phase 4Unknown

Sponsor
Xuzhou Central Hospital
Start
Apr 2021
Primary completion
Dec 2021
Modality
Small Molecules
01

Overview

A Phase 4 trial of nicorandil in myocardial infarction (MI), sponsored by Xuzhou Central Hospital. Status: unknown.

02

Drugs

nicorandil
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on NCT04826497.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04826497.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call